Greystone Managed Investments Inc. Buys 1,330 Shares of Zoetis Inc. (ZTS)
Greystone Managed Investments Inc. increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 1.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,570 shares of the company’s stock after buying an additional 1,330 shares during the quarter. Greystone Managed Investments Inc.’s holdings in Zoetis were worth $7,241,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. grew its stake in Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after purchasing an additional 230 shares during the period. Harfst & Associates Inc. grew its stake in Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after purchasing an additional 260 shares during the period. Almanack Investment Partners LLC. bought a new position in Zoetis in the 2nd quarter valued at $119,000. Peddock Capital Advisors LLC bought a new position in Zoetis in the 2nd quarter valued at $140,000. Finally, Parallel Advisors LLC grew its stake in Zoetis by 41.1% in the 2nd quarter. Parallel Advisors LLC now owns 2,263 shares of the company’s stock valued at $141,000 after purchasing an additional 659 shares during the period. Institutional investors and hedge funds own 93.37% of the company’s stock.
Shares of Zoetis Inc. (NYSE:ZTS) traded up $1.09 on Tuesday, reaching $72.04. The company had a trading volume of 818,556 shares, compared to its average volume of 2,803,857. The stock has a market cap of $34,490.00, a PE ratio of 32.47, a price-to-earnings-growth ratio of 2.07 and a beta of 1.02. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95. Zoetis Inc. has a twelve month low of $48.55 and a twelve month high of $71.14.
Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.52 EPS. research analysts predict that Zoetis Inc. will post 2.37 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be issued a dividend of $0.105 per share. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 dividend on an annualized basis and a yield of 0.58%. Zoetis’s dividend payout ratio (DPR) is 22.11%.
ZTS has been the subject of several research reports. Zacks Investment Research downgraded Zoetis from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Stifel Nicolaus reiterated a “buy” rating and set a $65.00 price target on shares of Zoetis in a research note on Friday, September 1st. Cantor Fitzgerald set a $75.00 price target on Zoetis and gave the stock a “buy” rating in a research note on Monday, August 14th. BidaskClub upgraded Zoetis from a “sell” rating to a “hold” rating in a research note on Friday, October 13th. Finally, Deutsche Bank AG downgraded Zoetis from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a research note on Tuesday, July 25th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the stock. Zoetis presently has a consensus rating of “Buy” and a consensus target price of $67.65.
COPYRIGHT VIOLATION WARNING: “Greystone Managed Investments Inc. Buys 1,330 Shares of Zoetis Inc. (ZTS)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/11/21/greystone-managed-investments-inc-buys-1330-shares-of-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).
Receive News & Stock Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related stocks with our FREE daily email newsletter.